Cargando…
Early Clinical Remission Is a Predictor of Long-Term Remission with the Use of Vedolizumab for Ulcerative Colitis
Vedolizumab (VDZ) is an α4β7 integrin-antibody used to manage refractory ulcerative colitis (UC). This retrospective multicenter study aimed to identify predictors of efficacy or the time points when evaluation of VDZ therapy for UC would be most useful. We compiled data on 87 patients with moderate...
Autores principales: | Haga, Keiichi, Shibuya, Tomoyoshi, Osada, Taro, Sato, Shunsuke, Fukuo, Yuka, Kobayashi, Osamu, Yamada, Toshio, Asaoka, Daisuke, Ito, Kentaro, Nomura, Kei, Haraikawa, Mayuko, Nomura, Osamu, Fukushima, Hirofumi, Murakami, Takashi, Ishikawa, Dai, Hojo, Mariko, Nagahara, Akihito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599457/ https://www.ncbi.nlm.nih.gov/pubmed/36289788 http://dx.doi.org/10.3390/biomedicines10102526 |
Ejemplares similares
-
Differential diagnosis of ulcerative colitis with increased diarrhea;
collagenous colitis or irritable bowel syndrome? A case report
por: Haraikawa, Mayuko, et al.
Publicado: (2022) -
Enterolith Treated with a Combination of Double-Balloon Endoscopy and Cola Dissolution Therapy
por: Nomura, Kei, et al.
Publicado: (2023) -
A Comparative Study of Early Mucosal Healing Following Hot Polypectomy and Cold Polypectomy
por: Fukushima, Hirofumi, et al.
Publicado: (2021) -
Successful remission of ulcerative colitis flare-up during pregnancy with adsorptive granulomonocytapheresis plus tacrolimus
por: Shibuya, Tomoyoshi, et al.
Publicado: (2018) -
Effectiveness and Nephrotoxicity of Long-Term Tacrolimus Administration in Patients with Ulcerative Colitis
por: Haga, Keiichi, et al.
Publicado: (2020)